EP0685232A3 - Formulation contenant céfixime. - Google Patents

Formulation contenant céfixime. Download PDF

Info

Publication number: EP0685232A3
Authority: EP; European Patent Office
Prior art keywords: formulation containing; cefixime; micron; max; particles
Prior art date: 1994-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP95107930A

Other languages

German (de)

English (en)

Other versions

EP0685232B1 (fr

EP0685232A2 (fr

Inventor

Joachim Dr Bolz

Gertraud Wagner

Eckhard Dr Oelrich

Dirk Radtke

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-31

Filing date

1995-05-24

Publication date

1996-05-08

1995-05-24 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

1995-12-06 Publication of EP0685232A2 publication Critical patent/EP0685232A2/fr

1996-05-08 Publication of EP0685232A3 publication Critical patent/EP0685232A3/fr

2000-03-22 Application granted granted Critical

2000-03-22 Publication of EP0685232B1 publication Critical patent/EP0685232B1/fr

2015-05-24 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cephalosporin Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP95107930A 1994-05-31 1995-05-24 Formulation contenant céfixime Expired - Lifetime EP0685232B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4418957A DE4418957A1 (de)	1994-05-31	1994-05-31	Cefixim-Zubereitung
DE4418957		1994-05-31

Publications (3)

Publication Number	Publication Date
EP0685232A2 EP0685232A2 (fr)	1995-12-06
EP0685232A3 true EP0685232A3 (fr)	1996-05-08
EP0685232B1 EP0685232B1 (fr)	2000-03-22

Family

ID=6519407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP95107930A Expired - Lifetime EP0685232B1 (fr)	1994-05-31	1995-05-24	Formulation contenant céfixime

Country Status (25)

Country	Link
US (1)	US5776926A (fr)
EP (1)	EP0685232B1 (fr)
JP (1)	JPH07330607A (fr)
KR (1)	KR950031077A (fr)
CN (1)	CN1117383A (fr)
AT (1)	ATE190844T1 (fr)
AU (1)	AU694201B2 (fr)
CA (1)	CA2150442A1 (fr)
CO (1)	CO4410174A1 (fr)
CZ (1)	CZ138595A3 (fr)
DE (2)	DE4418957A1 (fr)
DK (1)	DK0685232T3 (fr)
ES (1)	ES2146265T3 (fr)
FI (1)	FI952629A7 (fr)
GR (1)	GR3033704T3 (fr)
HU (1)	HU218217B (fr)
IL (1)	IL113917A0 (fr)
NO (1)	NO952138L (fr)
NZ (1)	NZ272216A (fr)
PE (1)	PE18796A1 (fr)
PL (1)	PL308838A1 (fr)
PT (1)	PT685232E (fr)
SK (1)	SK72795A3 (fr)
TW (1)	TW301610B (fr)
ZA (1)	ZA954427B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE216887T1 (de) *	1996-02-29	2002-05-15	Fujisawa Pharmaceutical Co	Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
TW200404550A (en) *	2002-07-08	2004-04-01	Sankyo Co	Cepharospolin formulation for oral use
BRPI0418769A (pt) *	2004-05-10	2007-10-09	Lupin Ltd	composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima
WO2007119249A2 (fr) *	2006-04-13	2007-10-25	Lupin Limited	Compositions pharmaceutiques à base de céfixime
US9233112B2 (en)	2006-04-13	2016-01-12	Lupin Limited	Pharmaceutical compositions of cefixime
CN103301068B (zh) *	2013-07-08	2014-09-10	广东彼迪药业有限公司	一种头孢克肟干混悬剂剂及其制备方法
WO2015007571A1 (fr) *	2013-07-18	2015-01-22	Sandoz Ag	Mélanges de poudres pour formulations de sirop sec antibiotique
US11446236B2 (en)	2015-08-05	2022-09-20	Cmpd Licensing, Llc	Topical antimicrobial compositions and methods of formulating the same
US11173163B2 (en) *	2015-08-05	2021-11-16	Cmpd Licensing, Llc	Topical antimicrobial compositions and methods of formulating the same
US11793783B2 (en)	2015-08-05	2023-10-24	Cmpd Licensing, Llc	Compositions and methods for treating an infection
US11684567B2 (en)	2015-08-05	2023-06-27	Cmpd Licensing, Llc	Compositions and methods for treating an infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4079138A (en) *	1975-01-02	1978-03-14	American Home Products Corporation	Permanent suspension pharmaceutical dosage forms
US5100887A (en) *	1988-02-17	1992-03-31	Hoechst Aktiengesellschaft	Cephalosporin derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5409917A (en) *	1991-03-05	1995-04-25	Marvin S. Towsend	Topical treatment of acne with cephalosporins

1994
- 1994-05-31 DE DE4418957A patent/DE4418957A1/de not_active Withdrawn
1995
- 1995-05-24 DE DE59508024T patent/DE59508024D1/de not_active Expired - Fee Related
- 1995-05-24 ES ES95107930T patent/ES2146265T3/es not_active Expired - Lifetime
- 1995-05-24 AT AT95107930T patent/ATE190844T1/de not_active IP Right Cessation
- 1995-05-24 EP EP95107930A patent/EP0685232B1/fr not_active Expired - Lifetime
- 1995-05-24 DK DK95107930T patent/DK0685232T3/da active
- 1995-05-24 PT PT95107930T patent/PT685232E/pt unknown
- 1995-05-25 JP JP7126029A patent/JPH07330607A/ja active Pending
- 1995-05-26 NZ NZ272216A patent/NZ272216A/en unknown
- 1995-05-26 AU AU20335/95A patent/AU694201B2/en not_active Ceased
- 1995-05-26 PE PE1995269744A patent/PE18796A1/es not_active Application Discontinuation
- 1995-05-29 CN CN95105585A patent/CN1117383A/zh active Pending
- 1995-05-29 TW TW084105413A patent/TW301610B/zh active
- 1995-05-29 CA CA002150442A patent/CA2150442A1/fr not_active Abandoned
- 1995-05-30 NO NO952138A patent/NO952138L/no unknown
- 1995-05-30 CO CO95023183A patent/CO4410174A1/es unknown
- 1995-05-30 HU HU9501570A patent/HU218217B/hu not_active IP Right Cessation
- 1995-05-30 ZA ZA954427A patent/ZA954427B/xx unknown
- 1995-05-30 PL PL95308838A patent/PL308838A1/xx unknown
- 1995-05-30 KR KR1019950013788A patent/KR950031077A/ko not_active Ceased
- 1995-05-30 CZ CZ951385A patent/CZ138595A3/cs unknown
- 1995-05-30 IL IL11391795A patent/IL113917A0/xx unknown
- 1995-05-30 FI FI952629A patent/FI952629A7/fi unknown
- 1995-05-31 SK SK727-95A patent/SK72795A3/sk unknown
1997
- 1997-03-03 US US08/806,757 patent/US5776926A/en not_active Expired - Fee Related
2000
- 2000-06-16 GR GR20000401394T patent/GR3033704T3/el unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4079138A (en) *	1975-01-02	1978-03-14	American Home Products Corporation	Permanent suspension pharmaceutical dosage forms
US5100887A (en) *	1988-02-17	1992-03-31	Hoechst Aktiengesellschaft	Cephalosporin derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROBERT D. FAULKNER ET AL.: "Bioequivalency of oral suspension formulations of cefixime", BIOPHARMACEUTICS & DRUG DISPOSITION, vol. 10, no. 2, pages 205 - 211, XP000607985 *

Also Published As

Publication number	Publication date
CZ138595A3 (en)	1996-04-17
TW301610B (fr)	1997-04-01
AU694201B2 (en)	1998-07-16
DE4418957A1 (de)	1995-12-07
US5776926A (en)	1998-07-07
DK0685232T3 (da)	2000-08-21
HU218217B (hu)	2000-06-28
CA2150442A1 (fr)	1995-12-01
HUT74421A (en)	1996-12-30
PE18796A1 (es)	1996-06-04
CO4410174A1 (es)	1997-01-09
PL308838A1 (en)	1995-12-11
JPH07330607A (ja)	1995-12-19
NO952138D0 (no)	1995-05-30
HU9501570D0 (en)	1995-07-28
IL113917A0 (en)	1995-08-31
DE59508024D1 (de)	2000-04-27
GR3033704T3 (en)	2000-10-31
AU2033595A (en)	1995-12-07
ATE190844T1 (de)	2000-04-15
SK72795A3 (en)	1996-01-10
NO952138L (no)	1995-12-01
FI952629L (fi)	1995-12-01
ZA954427B (en)	1996-01-24
PT685232E (pt)	2000-08-31
EP0685232B1 (fr)	2000-03-22
NZ272216A (en)	1996-05-28
FI952629A7 (fi)	1995-12-01
ES2146265T3 (es)	2000-08-01
CN1117383A (zh)	1996-02-28
KR950031077A (ko)	1995-12-18
EP0685232A2 (fr)	1995-12-06
FI952629A0 (fi)	1995-05-30

Legal Events

Date	Code	Title	Description
1995-10-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-12-06	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1995-12-06	RAX	Requested extension states of the european patent have changed	Free format text: LT PAYMENT 950524;SI PAYMENT 950524
1996-03-22	PUAL	Search report despatched	Free format text: ORIGINAL CODE: 0009013
1996-05-08	AK	Designated contracting states	Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1996-05-08	AX	Request for extension of the european patent	Free format text: LT PAYMENT 950524;SI PAYMENT 950524
1996-12-11	17P	Request for examination filed	Effective date: 19961010
1997-03-05	17Q	First examination report despatched	Effective date: 19970117
1999-05-19	GRAG	Despatch of communication of intention to grant	Free format text: ORIGINAL CODE: EPIDOS AGRA
1999-08-25	GRAG	Despatch of communication of intention to grant	Free format text: ORIGINAL CODE: EPIDOS AGRA
1999-08-25	GRAH	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOS IGRA
1999-11-23	GRAH	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOS IGRA
2000-02-04	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2000-03-22	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
2000-03-22	AX	Request for extension of the european patent	Free format text: LT PAYMENT 19950524;SI PAYMENT 19950524
2000-03-22	LTIE	Lt: invalidation of european patent or patent extension
2000-03-22	REF	Corresponds to:	Ref document number: 190844 Country of ref document: AT Date of ref document: 20000415 Kind code of ref document: T
2000-03-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2000-04-27	REF	Corresponds to:	Ref document number: 59508024 Country of ref document: DE Date of ref document: 20000427
2000-05-03	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN
2000-05-04	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: SE Payment date: 20000504 Year of fee payment: 6
2000-05-10	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20000510 Year of fee payment: 6
2000-05-11	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DK Payment date: 20000511 Year of fee payment: 6 Ref country code: AT Payment date: 20000511 Year of fee payment: 6
2000-05-24	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: IE Payment date: 20000524 Year of fee payment: 6 Ref country code: GB Payment date: 20000524 Year of fee payment: 6
2000-05-26	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GR Payment date: 20000526 Year of fee payment: 6 Ref country code: CH Payment date: 20000526 Year of fee payment: 6
2000-05-30	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: LU Payment date: 20000530 Year of fee payment: 6
2000-05-31	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: NL Payment date: 20000531 Year of fee payment: 6 Ref country code: ES Payment date: 20000531 Year of fee payment: 6
2000-06-19	ITF	It: translation for a ep patent filed
2000-06-27	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: PT Payment date: 20000627 Year of fee payment: 6
2000-07-12	GBT	Gb: translation of ep patent filed (gb section 77(6)(a)/1977)	Effective date: 20000616
2000-07-17	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: BE Payment date: 20000717 Year of fee payment: 6
2000-07-21	ET	Fr: translation filed
2000-08-01	REG	Reference to a national code	Ref country code: ES Ref legal event code: FG2A Ref document number: 2146265 Country of ref document: ES Kind code of ref document: T3
2000-08-21	REG	Reference to a national code	Ref country code: DK Ref legal event code: T3
2000-08-31	REG	Reference to a national code	Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20000531
2001-01-19	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2001-01-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2001-03-07	26N	No opposition filed
2001-05-24	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010524 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010524 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010524 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010524 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010524
2001-05-25	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010525 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010525
2001-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010531 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010531
2001-06-23	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010623 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010623
2001-11-30	BERE	Be: lapsed	Owner name: MERCK PATENT G.M.B.H. Effective date: 20010531
2001-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20011130
2001-12-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20011201
2002-01-15	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2002-01-16	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20010524
2002-01-21	REG	Reference to a national code	Ref country code: DK Ref legal event code: EBP
2002-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020131
2002-02-01	NLV4	Nl: lapsed or anulled due to non-payment of the annual fee	Effective date: 20011201
2002-03-06	REG	Reference to a national code	Ref country code: IE Ref legal event code: MM4A
2002-03-28	REG	Reference to a national code	Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20011130
2003-04-01	REG	Reference to a national code	Ref country code: ES Ref legal event code: FD2A Effective date: 20030303
2004-06-03	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20040603 Year of fee payment: 10
2005-05-24	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050524
2005-12-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051201

Publication	Publication Date	Title
CA2000960A1 (fr)	1990-04-19	Insecticide
TW349849B (en)	1999-01-11	Xanthan gelling agents
CA2181172A1 (fr)	1996-06-23	Compositions de prostaglandine stables au stockage
EP0685232A3 (fr)	1996-05-08	Formulation contenant céfixime.
CA2310222A1 (fr)	1999-05-27	Nouvelle composition de matiere
CA2142126A1 (fr)	1994-03-03	Poudre a inhaler, renfermant un agent antistatique
EP0630580A3 (fr)	1995-09-13	Gomme gellan sous forme de microparticules recouvertes d'huile.
PH25126A (en)	1991-02-19	1,5-diaryl-3-substituted pyrazoles pharmaceutical compositions and use
CA2151967A1 (fr)	1996-02-16	Compositions magnetiques nanocomposites et procedes de fabrication connexes
HUT41951A (en)	1987-06-29	Process for producing insecticide compositions containing fluorinated ethers as active agents and process for producing the active agents
SE9700134D0 (sv)	1997-01-20	New formulation
CA2011452A1 (fr)	1990-09-18	Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one
CA2016968A1 (fr)	1991-02-23	Composition d'assainissement de l'air
DE69500027D1 (de)	1996-09-26	Gelartige kosmetische und/oder dermatologische Zusammensetzung enthaltend hohle Teilchen und eine grosse Menge an Lösungsmittel
EP0658596A3 (fr)	1995-10-18	Composition à base de biopolymères à hydratation rapide.
IL99501A0 (en)	1992-08-18	Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
HUT41230A (en)	1987-04-28	Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
CA2047802A1 (fr)	1992-01-26	Compositions pharmaceutiques
HUT44011A (en)	1988-01-28	Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
BG102909A (en)	1999-05-31	Instant vesicular product
HUT46838A (en)	1988-12-28	Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
DE69703460D1 (de)	2000-12-14	Natriumpercarbonat und Verfahren zu dessen Herstellung
IT1201431B (it)	1989-02-02	Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene
FR2575070B3 (fr)	1987-02-20	Composition a effet assainissant, en particulier pour le parfumage d'air ambiant
AU9541898A (en)	1999-05-03	Azines containing the 5,6-di-hydro-(1,4,2) dioxazine-3-yl group and the use thereof as fungicides